Polycyclic compound
US9453000B2 · kind B2 · utility
0Cited by
24References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2008 |
| Grant date | Sep 27, 2016 |
| Priority date | — |
| Expiry date | Jan 11, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed is a compound represented by the formula (I):or a pharmacologically acceptable salt thereof, which is effective as a therapeutic or prophylactic agent for a disease induced by Aβ, wherein Ar1 represents an imidazolyl group which may be substituted with a C1-6 alkyl group, or the like; Ar2 represents a phenyl group which may be substituted with a C1-6 alkoxy group, or the like; X1 represents a double bond, or the like; and Het represents a triazolyl group or the like which may be substituted with a C1-6 alkyl group or the like, or the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.